Revenue by source
Innovative Medicine$60.40BPharmaceutical$0.00MedTech$33.79BMedical Devices$0.00Consumer$0.00
| Segment | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Innovative Medicine | - | - | - | - | - | $33.46B | $36.26B | $40.73B | $42.20B | - | - | $52.56B | $54.76B | $56.96B | $60.40B |
| Pharmaceutical | $24.37B | $25.35B | $28.13B | $32.31B | $31.43B | - | - | - | - | $45.18B | $52.08B | - | - | - | - |
| MedTech | - | - | - | - | - | $25.12B | $26.59B | $26.99B | $25.96B | - | - | $27.43B | $30.40B | $31.86B | $33.79B |
| Medical Devices | $25.78B | $27.43B | $28.49B | $27.52B | $25.14B | - | - | - | - | $22.96B | $27.06B | - | - | - | - |
| Consumer | $14.88B | $14.45B | $14.70B | $14.50B | $13.51B | $13.31B | $13.60B | $13.85B | $13.90B | $14.45B | $14.64B | $14.95B | - | - | - |
Revenue by country
UNITED STATES$53.75BEurope$21.54BAsia-Pacific, Africa$14.03BWestern Hemisphere, excluding U.S.$4.88B
| Segment | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| UNITED STATES | $29.45B | $28.91B | $29.83B | $31.91B | $34.78B | $35.69B | $37.81B | $39.86B | $41.88B | $42.10B | $43.13B | $47.16B | $48.58B | $46.44B | $50.30B | $53.75B |
| Europe | $15.51B | $17.13B | $16.95B | $18.60B | $18.95B | $16.00B | $15.77B | $17.13B | $18.75B | $18.47B | $18.98B | $23.59B | $23.45B | $20.41B | $20.21B | $21.54B |
| Asia-Pacific, Africa | $11.08B | - | - | $13.38B | $13.44B | $12.35B | $12.58B | $13.42B | $14.83B | $15.56B | $15.14B | $17.28B | $16.79B | $13.76B | $13.59B | $14.03B |
| Western Hemisphere, excluding U.S. | - | - | - | $7.42B | $7.16B | $6.05B | $5.73B | $6.04B | $6.11B | $5.94B | $5.34B | $5.75B | $6.13B | $4.55B | $4.71B | $4.88B |